The use of a left ventricular assist device (LVAD) as a bridge-to-transplantation or
destination therapy to support cardiac function in patients with end-stage heart failure (HF) is …

Background Left ventricular (LV) assist devices (LVADs) can prolong survival and improve
quality of life in end‐stage heart failure. Aims Review outcomes of the Western Australian …

Background Beliefs around deactivation of a left ventricular assist device (LVAD) vary
substantially among clinicians, institutions, and patients. Therefore, we sought to understand …

The goal of this study was to assess outcomes of patients who underwent implantation of left
ventricular assist devices (LVADs) at nontransplantation mechanical circulatory support …

Aims The need for the left ventricular assist devices (LVAD) in patients with end‐stage heart
failure is well established, but prior to 2011, this was not available to patients in Kazakhstan …

Objectives. Over recent decades implantable left ventricular assist devices (LVAD) have
increased the possibility of improved survival in patients with advanced heart failure who …

Background Frailty is recognized as a major prognostic indicator in heart failure. There has
been interest in understanding whether pre-operative frailty is associated with worse …

Background A left ventricular assist device (LVAD) is a life-saving but intensive therapy for
patients with end-stage heart failure. We evaluated the healthcare consumption in a cohort …

Objectives The aim of this study was to analyze our 10-year experience with the HVAD in a
real-world scenario in a high-volume German heart center. Methods We retrospectively …

Background Heart Failure is an epidemic with a current prevalence of over 5.8 million
patients in the USA and almost 23 million patients worldwide, with high associated mortality …